Login to Your Account

Bayer Buying Pharmacogenomics Firm Visible Genetics For $61.4M

By Aaron Lorenzo

Wednesday, July 24, 2002
Bayer Corp. is scooping up Visible Genetics Inc. for $61.4 million in cash as the parties signed a definitive agreement for a deal that brings to Bayer VGI's Trugene HIV-1 Genotyping Kit and OpenGene DNA Sequencing System. (Bioworld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription